China National Medicines Corp Ltd
SSE:600511
Wall Street
Price Targets
Price Targets Summary
China National Medicines Corp Ltd
According to Wall Street analysts, the average 1-year price target for China National Medicines Corp Ltd is 45.19 CNY with a low forecast of 41.41 CNY and a high forecast of 49.98 CNY.
Price Targets
Operating Income
Forecast
Operating Income Estimate
China National Medicines Corp Ltd
For the last 8 years the compound annual growth rate for China National Medicines Corp Ltd's operating income is 20%. The projected CAGR for the next 3 years is 15%.
Net Income
Forecast
Net Income Estimate
China National Medicines Corp Ltd
For the last 8 years the compound annual growth rate for China National Medicines Corp Ltd's net income is 20%. The projected CAGR for the next 3 years is 12%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is China National Medicines Corp Ltd's stock price target?
Price Target
45.19
CNY
According to Wall Street analysts, the average 1-year price target for China National Medicines Corp Ltd is 45.19 CNY with a low forecast of 41.41 CNY and a high forecast of 49.98 CNY.
What is China National Medicines Corp Ltd's Revenue forecast?
Projected CAGR
10%
For the last 8 years the compound annual growth rate for China National Medicines Corp Ltd's revenue is 19%. The projected CAGR for the next 3 years is 10%.
What is China National Medicines Corp Ltd's Operating Income forecast?
Projected CAGR
15%
For the last 8 years the compound annual growth rate for China National Medicines Corp Ltd's operating income is 20%. The projected CAGR for the next 3 years is 15%.
What is China National Medicines Corp Ltd's Net Income forecast?
Projected CAGR
12%
For the last 8 years the compound annual growth rate for China National Medicines Corp Ltd's net income is 20%. The projected CAGR for the next 3 years is 12%.